67553-36-0

Basic information

• Product Name: L-Serine, N-(triphenylmethyl)-, phenylmethyl ester
• CAS NO: 67553-36-0
• Molecular Formula: C29H27NO3
• Molecular Weight: 437.538
• Mol File: 67553-36-0.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: L-Serine, N-(triphenylmethyl)-, phenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: L-Serine, N-(triphenylmethyl)-, phenylmethyl ester(67553-36-0)
• EPA Substance Registry System: L-Serine, N-(triphenylmethyl)-, phenylmethyl ester(67553-36-0)

Safety Data

• Hazardous Substances Data: 67553-36-0(Hazardous Substances Data)

Upstream product

• 88109-06-2 3(S)-<(triphenylmethyl)amino>-2-oxetanone 
• 100-51-6 benzyl alcohol 
• 60022-62-0 L-serine benzyl ester hydrochloride 
• 76-83-5 trityl chloride 
• 1738-72-3 L-serine benzyl ester 

Downstream Products

• 142941-68-2 (S)-2-Oxo-3-trityl-2λ⁴-[1,2,3]oxathiazolidine-4-carboxylic acid benzyl ester 
• 153617-40-4 (S)-N-Trityl-β-chloroalanine benzyl ester 
• 83824-80-0 benzyl (2S)-1-benzyloxycarbonyl-aziridine-2-carboxylate 
• 1206598-46-0 C₄₂H₄₈N₂O₄Si 
• 157878-50-7 (S)-1-Trityl-aziridine-2-carboxylic acid pentafluorophenyl ester 
• 67413-26-7 L-aziridine-2-carboxylic acid benzyl ester 
• 84771-33-5 (2S)-1-trityl-aziridine-2-carboxylic acid 
• 918650-15-4 phenylmethyl (2S)-3-(3-{(2S)-2-[(3,3-dimethyl-3-silabutyl)oxycarbonyl]-2-[(phenylmethoxy)carbonylamino]ethyl}phenoxy)-2-[(triphenylmethyl)amino]propanoate 
• 181637-41-2 N-trityl-β-iodo-α-alanine benzyl ester 

Relevant articles and documents

Oligo(serine ester) Charge-Altering Releasable Transporters: Organocatalytic Ring-Opening Polymerization and their Use for in Vitro and in Vivo mRNA Delivery

RNA technology is transforming life science research and medicine, but many applications are limited by the accessibility, cost, efficacy, and tolerability of delivery systems. Here we report the first members of a new class of dynamic RNA delivery vector

Selective Targeting of the TPX2 Site of Importin-α Using Fragment-Based Ligand Design

Protein-protein interactions are difficult therapeutic targets, and inhibiting pathologically relevant interactions without disrupting other essential ones presents an additional challenge. Herein we report how this might be achieved for the potential ant